Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNephrology Physician in La Jolla, CA
NPI: 1437154978Primary Practice Location
Scripps Clinic La Jolla- Poole Building
9834 Genesee Ave, La Jolla, CA
Primary Employer
Balboa Nephrology Medical Group Inc
balboacare.com
HQ Phone
Get M.D. Dylan's Phone Numberphone_androidMobile
Get M.D. Dylan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1998 - 2025
NC State Medical License
1997 - 1998
American Board of Internal Medicine
Nephrology
Duke University School Of Medicine
medschool.duke.edu
Medical School
Until 1995
University of California (San Diego) Medical Center
Fellowship • Nephrology
2000 - 2003
Duke University Hospital
Residency • Internal Medicine
1995 - 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 61 | 126 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 18 | 42 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 14 | 15 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 12 | 12 |
A strategy for in vitro propagation of rat nephrons.
Authors: Steer, Dylan L, Bush, Kevin T, Meyer, Tobias N, Schwesinger, Catherine, Nigam, Sanjay K
Journal: Kidney Int
Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis.
Authors: William Wachsman
Publication Date: 2001-12
Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney
Authors: Tobias N. Meyer, Catherine Schwesinger, Kevin T. Bush, Robert O. Stuart, David W. Rose, Mita M. Shah, Duke A. Vaughn, Dylan L. Steer, Sanjay K. Nigam
Publication Date: 2004-11
Lead Sponsor: California Institute of Renal Research
Collaborators: Imprimis Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Topical Tranexamic Acid 5% with bacitracin, OTHER: Topical Tranexamic Acid 25% with bacitracin
